Liraglutide reduces lipogenetic signals in visceral adipose of db/db mice with AMPK activation and Akt suppression

Liraglutide reduces lipogenetic signals in visceral adipose of db/db mice with AMPK activation and Akt suppression

Yimin Shao, Geheng Yuan, Junqing Zhang, Xiaohui Guo Department of Endocrinology, Peking University First Hospital, Beijing, People’s Republic of China Abstract: Liraglutide, a glucagon-like peptide-1 analog, has been proved to reduce body weight and visceral adipose tissue (VAT) in huma...

Full description

Bibliographic Details
Main Authors: Shao Y, Yuan G, Zhang J, Guo X
Format: Article
Language:English
Published: Dove Medical Press 2015-02-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/liraglutide-reduces-lipogenetic-signals-in-visceral-adipose-of-dbdb-mi-peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/liraglutide-reduces-lipogenetic-signals-in-visceral-adipose-of-dbdb-mi-peer-reviewed-article-DDDT

Similar Items